Tachycardia-induced primate model of heart failure in cardiovascular drug discovery.

Smith, A H; Wolfgang, E A; Flynn, D M; Doe, C P; Knight, D R

Smith, A H; Wolfgang, E A; Flynn, D M; Doe, C P; Knight, D R.

Affiliation

Smith AH; Department of Cardiovascular and Metabolic Diseases, Pfizer Central Research, Pfizer Inc., Eastern Point Road, Groton, CT 06340, USA.

J Pharmacol Toxicol Methods ; 43(2): 125-31, 2000.

Article in En | MEDLINE | ID: mdl-11150740

Subject(s)

Cardiovascular Agents/therapeutic use; Disease Models, Animal; Heart Failure/etiology; Tachycardia/complications; Animals; Heart Failure/drug therapy; Macaca fascicularis; Ventricular Dysfunction, Left/etiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tachycardia / Cardiovascular Agents / Disease Models, Animal / Heart Failure Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: J Pharmacol Toxicol Methods Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2000 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links